Metraipolis › archive › dc_59f8b2ca83f6

QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial — Europe PMC PMID:41666130

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41666130
DOI
10.1371/journal.pgph.0005113
License (as archived)
solo-consultazione
Archived
2026-11-05T23:48:18.512Z
SHA-256 of the archived text
d51c4bb15b51e65daada101488935953e34a6d914d677d01b54075e219f2ae04
Stable URL of this page
https://metraipolis.com/documento/dc_59f8b2ca83f6

How to cite

QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial — Europe PMC PMID:41666130 — Europe PMC (en), https://europepmc.org/article/MED/41666130 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_59f8b2ca83f6 (Metraipolis archive dc_59f8b2ca83f6, sha256 d51c4bb15b51e65daada101488935953e34a6d914d677d01b54075e219f2ae04)
BibTeX
@misc{dc59f8b2ca83f6,
  title = {QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial — Europe PMC PMID:41666130},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41666130},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_59f8b2ca83f6; sha256 d51c4bb15b51e65daada101488935953e34a6d914d677d01b54075e219f2ae04},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41666130. Agents can read the archived copy with the MCP tool read_document.